Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lung cancer metastatic
ADR ID BADD_A04901
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.02      Respiratory tract and pleural neoplasms malignant cell type unspecified NEC
16.19.02.003      Lung cancer metastatic
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.004      Lung cancer metastatic
Description Not Available
MedDRA Code 10050017
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Lung cancer metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00100Ambrisentan0.000120%
BADD_D00285Bosentan0.000241%
BADD_D00414Ceritinib0.000168%
BADD_D00511Clozapine0.026292%
BADD_D00535Crizotinib0.001533%
BADD_D00563Dabigatran0.000734%
BADD_D00564Dabigatran etexilate--
BADD_D00680Dimethyl fumarate0.001400%
BADD_D00800Erlotinib0.001791%
BADD_D00854Etoposide--
BADD_D00879Fentanyl0.000634%
BADD_D00978Fulvestrant0.000334%
BADD_D01119Ibrutinib0.000280%
BADD_D01196Irinotecan hydrochloride--
BADD_D01253Lenalidomide--
BADD_D01260Leuprolide acetate0.002151%
BADD_D01378Memantine0.000181%
BADD_D01418Methotrexate0.000284%
BADD_D01629Osimertinib0.000280%
BADD_D01653Paclitaxel0.000280%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01834Prednisone0.000009%
BADD_D01846Procarbazine--
BADD_D01913Ranitidine0.000050%
BADD_D01933Ribavirin0.003956%
BADD_D01954Rivaroxaban0.000285%
BADD_D01978Ruxolitinib0.000137%
BADD_D02010Sertraline0.000019%
BADD_D02192Thalidomide0.000241%
The 1th Page    1 2    Next   Last    Total 2 Pages